Clinical trial
A phase 2, open-label, single-arm, efficacy and safety study of MDV3100 in patients with hormone-na�ve prostate cancer
To evaluate the effect of MDV3100 on prostate-specific antigen (PSA)
| Category | Value |
|---|---|
| Study start date | 2011-02-25 |